An estimated 234,680 new cases of melanoma will be diagnosed in the United States this year, according to the American Cancer Society. Nearly 20 Americans die from it every day. Yet when melanoma is caught before it spreads, the five-year survival rate sits above 99 percent. The gap between those two numbers is, increasingly, a technology problem — and a growing number of people are turning to artificial intelligence to close it.
The Detection Gap
Dermatologists have long recommended monthly self-examinations, but research shows most people never do them — or do them poorly. Half of all melanomas are self-detected, often by accident rather than routine. Even those who schedule annual skin checks can develop fast-changing lesions between appointments. Access is another barrier: wait times for dermatology referrals in the UK, Australia, and parts of the US can stretch to several months.
This is where smartphone-based screening tools are beginning to change the equation. A new generation of AI-powered apps now allows users to photograph a mole, rash, or lesion and receive a preliminary risk assessment within seconds. The technology does not replace a doctor, but it is designed to help people decide whether a spot warrants professional attention — and to do so before a concerning change goes unnoticed for months.
How the AI Works
Most consumer skin-screening apps rely on deep learning models trained on large datasets of clinical images. These systems learn to distinguish visual patterns associated with different conditions — asymmetry, irregular borders, colour variation, and diameter, the same criteria dermatologists use in the well-known ABCDE framework.
One platform gaining traction in this space is ScanSkinAI, a skin health check app developed by London-based Ivy AI Solutions. The app uses a DINOv2 vision transformer — a type of AI model originally developed by Meta for image recognition — fine-tuned to classify 31 skin condition categories. In clinical validation testing, the system reported a 96.48 percent accuracy rate across its classification range, with melanoma-specific sensitivity reaching 96.7 percent. The platform is certified under ISO 27001 for data security and ISO 13485 for medical device quality management.
Users upload a photograph, receive an AI-generated analysis in approximately 30 seconds, and can then optionally request a review from a qualified dermatologist within 8 to 48 hours. The model is designed as a triage layer: identifying which spots need urgent attention and which are likely benign, rather than delivering a clinical diagnosis.
Why Timing Matters More Than People Think
The medical case for earlier screening is stark. Research published in JAMA Dermatology found that melanoma patients treated more than 119 days after biopsy face a 41 percent higher risk of death compared to those treated within 30 days. Separately, data from the American Academy of Dermatology shows melanoma incidence has risen by over 31 percent between 2011 and 2019, with rates in women over 50 continuing to climb by nearly 3 percent annually.
The financial toll is also significant. Approximately 6.1 million American adults are treated for basal cell and squamous cell carcinomas each year, at a combined cost of roughly $8.9 billion. Early detection, whether through a dermatologist visit or an AI-assisted screen, can dramatically reduce the complexity and cost of treatment.
Limitations and the Path Forward
No AI tool can fully replicate the clinical judgment of a trained dermatologist. Smartphone camera quality, lighting conditions, and skin tone diversity in training datasets remain active challenges across the industry. Most platforms, including ScanSkinAI, carry clear medical disclaimers and position themselves as screening aids rather than diagnostic devices.
Still, the direction is clear. A peer-reviewed study in the Annals of Oncology found that AI systems can now match or exceed the diagnostic accuracy of experienced dermatologists for certain lesion types. As these tools become more widely available and their datasets grow more representative, they stand to become a routine part of preventive health — particularly for the millions of people who currently have no practical access to specialist skin checks.
For now, dermatologists broadly agree on one point: any tool that prompts someone to take a closer look at a suspicious mole is a step in the right direction. The smartphone in your pocket may not replace your doctor, but it could be the nudge that gets you to one sooner.
Media Contact
Company Name: Scan Skin
Email: Send Email
Country: United States
Website: https://www.scanskinai.com/